pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 2·1 min read
save

Ig Nobel Prizes move to Zurich as organizers cite US immigration concerns

Sep 2, 2026·read at STAT ↗Neutral

The Ig Nobel Prizes, a tongue-in-cheek science award, will be held outside the United States for the first time since they began in 1991.

Organizers said the move to Zurich, Switzerland, reflects concerns that international scientists and journalists may feel unsafe or face travel hurdles because of the Trump administration’s immigration policies.

The ceremony, traditionally staged in Cambridge, Massachusetts, will take place in Zurich, marking a historic shift for the quirky event.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The Ig Nobel Prizes, long held in the U.S., head to Europe due to Trump policies”

read at STAT ↗
415 words · retrieved Sep 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
OVERSEAS

related stories

  • Aug 10AstraZeneca partners with CSPC to build Chinese biologics manufacturing plantBioSpace
  • Aug 10FDA warns firm in India for falsified logbooks; two other companies warned for lax testingraps
  • Aug 3Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls outBioSpace
  • Jul 31Syphilis spreads while researchers contend with federal constraints and a drug shortageSTAT
  • Jul 16‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsFierce Biotech